NCT07735637
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07735637
Title A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6). (DURGA-6)
Acronym DURGA-6
Recruitment Not yet recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | POL | NOR | ITA | GBR | FRA | ESP | DNK | DEU | CAN | BRA | AUS

Facility Status City State Zip Country Details
Research Site Tampa Florida 33612 United States Details
Research Site Atlanta Georgia 30322 United States Details
Research Site Atlanta Georgia 30342 United States Details
Research Site Chicago Illinois 60637 United States Details
Research Site Detroit Michigan 48201 United States Details
Research Site Rochester Minnesota 55905 United States Details
Research Site Cleveland Ohio 44195 United States Details
Research Site San Antonio Texas 78229 United States Details
Research Site Seattle Washington 98104 United States Details
Research Site Milwaukee Wisconsin 53226 United States Details
Research Site Brisbane 4102 Australia Details
Research Site Camperdown 2050 Australia Details
Research Site Darlinghurst 2010 Australia Details
Research Site Fitzroy VIC3065 Australia Details
Research Site Melbourne 3004 Australia Details
Research Site Nedlands 6009 Australia Details
Research Site Salvador 41253-190 Brazil Details
Research Site São Paulo 01509-900 Brazil Details
Research Site São Paulo 05652-900 Brazil Details
Research Site Calgary Alberta T2N 5G2 Canada Details
Research Site Aarhus 8200 Denmark Details
Research Site København Ø 2100 Denmark Details
Research Site Odense 5464 Denmark Details
Research Site Lille 59037 France Details
Research Site Nantes 44093 France Details
Research Site Paris 75012 France Details
Research Site Paris 75475 France Details
Research Site Toulouse 31059 France Details
Research Site Berlin 10117 Germany Details
Research Site Dresden 01307 Germany Details
Research Site Essen 45122 Germany Details
Research Site Freiburg im Breisgau 79106 Germany Details
Research Site Hamburg 20246 Germany Details
Research Site Leipzig 04103 Germany Details
Research Site München 81675 Germany Details
Research Site Oldenburg 26133 Germany Details
Research Site Bologna 40138 Italy Details
Research Site Milan 20133 Italy Details
Research Site Milan 20141 Italy Details
Research Site Rome 00168 Italy Details
Research Site Rozzano 20089 Italy Details
Research Site Torino 10100 Italy Details
Research Site Oslo 0450 Norway Details
Research Site Gdansk 80-214 Poland Details
Research Site Gliwice 44-100 Poland Details
Research Site Kielce 25-734 Poland Details
Research Site Krakow 30-688 Poland Details
Research Site Lublin 20-090 Poland Details
Research Site Wroclaw 50-556 Poland Details
Research Site Singapore 119228 Singapore Details
Research Site Singapore 169608 Singapore Details
Research Site Seoul 03080 South Korea Details
Research Site Seoul 06351 South Korea Details
Research Site Seoul 06591 South Korea Details
Research Site Seoul 5505 South Korea Details
Research Site Badalona 08916 Spain Details
Research Site Barcelona 08035 Spain Details
Research Site El Palmar 30120 Spain Details
Research Site Madrid 28034 Spain Details
Research Site Salamanca 37007 Spain Details
Research Site Santander 39008 Spain Details
Research Site Seville 41013 Spain Details
Research Site Taipei 106 Taiwan Details
Research Site Cambridge CB2 0QQ United Kingdom Details
Research Site London W12 0HS United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field